Are frontotemporal lobar degeneration, progressive supranuclear palsy and corticobasal degeneration distinct diseases?

Nature Clinical Practice Neurology

Volumn 2, Issue 12, 2006, Pages 658-665

  Sha, Sharon ^a   Hou, Craig ^b   Viskontas, Indre V ^c   Miller, Bruce L ^c  

^a CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

^b KAISER PERMANENTE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TAU PROTEIN;

APHASIA; AUTOPSY; BRAIN DEGENERATION; CELL INCLUSION; CLINICAL FEATURE; CORTICOBASAL DEGENERATION; DEGENERATIVE DISEASE; DISEASE CLASSIFICATION; FRONTOTEMPORAL LOBAR DEGENERATION; GENETIC ANALYSIS; GENETICS; HUMAN; MEDICAL LITERATURE; PATHOLOGY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; REVIEW; TAUOPATHY; VALIDITY;

ANIMALS; DEMENTIA; DIAGNOSIS, DIFFERENTIAL; HUMANS; NEURODEGENERATIVE DISEASES; SUPRANUCLEAR PALSY, PROGRESSIVE; TAU PROTEINS;

EID: 33751243067     PISSN: 1745834X     EISSN: 17458358     Source Type: Journal    
DOI: 10.1038/ncpneuro0357     Document Type: Review

References (60)

1. Kertesz A et al. (2003) Frontotemporal degeneration, Pick's disease, Pick complex, and Ravel. Ann Neurol 54 (Suppl 5): S1-S2
2. Kertesz A (2006) Progress in clinical neurosciences: Frontotemporal dementia-Pick's disease. Can J Neurol Sci 33: 141-148
3. Josephs KA et al. (2006) Clinicopathologic analysis of frontotemporal and corticobasal degenerations and PSP. Neurology 66: 41-48
4. Rebeiz JJ et al. (1968) Corticodentatonigral degeneration with neuronal achromasia. Arch Neurol 18: 20-33
5. Gibb WRG et al. (1989) Corticobasal degeneration. Brain 112: 1171-1192
6. Lelguarda R et al. (1994) The nature of apraxia in corticobasal degeneration. J Neurol Neurosurg Psychiatry 57: 455-459
7. Kertesz A et al. (2000) The corticobasal degeneration syndrome overlaps progressive aphasia and frontotemporal dementia. Neurology 55: 1368-1375
8. Leiguarda RC et al. (2003) Limb-kinetic apraxia in corticobasal degeneration: Clinical and kinematic features. Mov Disord 18: 49-59
9. Grimes DA et al. (1999) Dementia as the most common presentation of cortical-basal ganglionic degeneration. Neurology 53: 1969-1974
10. Pillon B et al. (1995) The neuropsychological pattern of corticobasal degeneration: Comparison with progressive supranuclear palsy and Alzheimer's disease. Neurology 45: 1477-1483
11. Dubois B et al. (2000) The FAB: A frontal assessment battery at bedside. Neurology 55: 1621-1626
12. Frattali CM et al. (2000) Language disturbances in corticobasal degeneration. Neurology 54: 990-992
13. Graham NL et al. (2003) Corticobasal degeneration as a cognitive disorder. Mov Disord 18: 1224-1232
14. Dickson DW et al. (2002) Office of Rare Diseases neuropathologic criteria for corticobasal degeneration. J Neuropathol Exp Neurol 61: 935-946
15. Bugiani O et al. (1999) Frontotemporal dementia and corticobasal degeneration in a family with a P301S mutation in tau. J Neuropathol Exp Neurol 58: 667-677
16. Morris HR et al. (1999) The tau gene AO polymorphism in progressive supranuclear palsy and related neurodegenerative diseases. J Neurol Neurosurg Psychiatry 66: 665-667
17. Steele JC et al. (1964) Progressive supranuclear palsy: A heterogeneous degeneration involving the brain stem, basal ganglia and cerebellum with vertical gaze and pseudobulbar palsy, nuchal dystonia and dementia. Arch Neurol 10: 333-359
18. Troost BT and Daroff RB (1977) The ocular motor defects in progressive supranuclear palsy. Ann Neurol 2: 397-403
19. Rivaud-Pechoux S et al. (2000) Longitudinal ocular motor study in corticobasal degeneration and progressive supranuclear palsy. Neurology 54: 1029-1032
20. Maher ER and Leas AJ (1986) The clinical features and natural history of the Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). Neurology 36: 1005-1008
21. Litvan I et al. (1996) Natural history of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) and clinical predictors of survival: A clinicopathological study. J Neurol Neurosurg Psychiatry 60: 615-620
22. Santacruz P et al. (1998) Progressive supranuclear palsy: A survey of the disease course. Neurology 50: 1637-1647
23. Litvan I et al. (1996) Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology 47: 1-9
24. Belfor N et al. (2006) Clinical and neuropsychological features of corticobasal degeneration. Mech Ageing Dev 127: 203-207
25. Davis PH et al. (1985) Atypical presentation of progressive supranuclear palsy. Ann Neurol 17: 337-343
26. Gearing M et al. (1994) Progressive supranuclear palsy: Neuropathologic and clinical heterogeneity. Neurology 44: 1015-1024
27. Albert ML et al. (1974) The 'subcortical dementia' of progressive supranuclear palsy. J Neurol Neurosurg Psychiatry 37: 121-130
28. Maher ER et al. (1985) Cognitive deficits in the Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). J Neurol Neurosurg Psychiatry 48: 1234-1239
29. Grafman J et al. (1990) Frontal lobe function in progressive supranuclear palsy. Arch Neurol 47: 553-558
30. Hauw JJ et al. (1994) Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). Neurology 44: 2015-2019
31. Wszolek ZK et al. (1998) Clinical neurophysiologic findings in patients with rapidly progressive familial parkinsonism and dementia with pallido-ponto-nigral degeneration. Electroencephalogr Clin Neurophysiol 107: 213-222
32. Conrad C et al. (1997) Genetic evidence for the involvement of tau in progressive supranuclear palsy. Ann Neurol 41: 277-281
33. Baker M et al. (1999) Association of an extended haplotype in the tau gene with progressive supranuclear palsy. Hum Mol Genet 8: 711-715
34. Flament S et al. (1991) Abnormal tau proteins in progressive supranuclear palsy: Similarities and differences with the neurofibrillary degeneration of the Alzheimer type. Acta Neuropathol (Berl) 81: 591-596
35. 42 fibrils. Science 293: 1491-1495
36. Roy S et al. (1974) Electron microscopic study of neurofibrillary tangles in Steele-Richardson-Olszewski syndrome. Acta Neuropathol (Berl) 29: 175-179
37. Pick A (1892) On the relationship between senile brain atrophy and aphasia [German]. Prager Medizinische Wochenschrift 17: 165-167
38. Alzheimer AC (1911) On peculiar cases of disease at higher age [German]. Zeitschrift für die gesamte Neurologie und Psychiatrie 4: 356-385
39. Onari K and Spatz H (1926) Anatomical contributions on Pick's circumscribed cerebral cortex atrophy (Pick's disease) [German]. Zeitschrift für die gesamte Neurologie und Psychiatrie 101: 470-511
40. [No authors listed] (1994) Clinical and neuropathological criteria for frontotemporal dementia. The Lund and Manchester groups. J Neurol Neurosurg Psychiatry 57: 416-418
41. Neary D et al. (1998) Frontotemporal lobar degeneration: A consensus on clinical diagnostic criteria. Neurology 51: 1546-1554
42. Mott RT et al. (2005) Neuropathologic, biochemical, and molecular characterization of the frontotemporal dementias. J Neuropathol Exp Neurol 64: 420-428
43. McKhann GM et al. (2001) Clinical and pathological diagnosis of frontotemporal dementia: Report of the Work Group on Frontotemporal Dementia and Pick's Disease. Arch Neurol 58: 1803-1809
44. Foster NL et al. (1997) Frontotemporal dementia and parkinsonism linked to chromosome 17: A consensus conference. Conference Participants. Ann Neurol 41: 706-715
45. Wilhelmsen KC et al. (1994) Localization of disinhibition-dementia-parkinsonism-amyotrophy complex to 17q21-22. Am J Hum Genet 55: 1159-1165
46. Baker M et al. (2006) Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17. Nature 442: 916-919
47. Morita M et al. (2006) A locus on chromosome 9p confers susceptibility to ALS and frontotemporal dementia. Neurology 66: 839-844
48. Hughes A et al. (2003) Tau haplotype frequency in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Exp Neurol 181: 12-16
49. Panegyres PK and Zafiris-Toufexis K (2002) Polymorphisms in the tau gene in sporadic frontotemporal dementia and other neurodegenerative disorders. Eur J Neurol 9: 485-489
50. Gorno-Tempini ML et al. (2004) Clinical, cognitive and anatomical evolution from nonfluent progressive aphasia to corticobasal syndrome: A case report. Neurocase 10: 426-436
51. Houlden H et al. (2001) Corticobasal degeneration and progressive supranuclear palsy share a common tau haplotype. Neurology 56: 1702-1706
52. Di Maria E et al. (2000) Corticobasal degeneration shares a common genetic background with progressive supranuclear palsy. Ann Neurol 47: 374-377
53. Feany MB and Dickson DW (1996) Neurodegenerative disorders with extensive tau pathology: A comparative study and review. Ann Neurol 40: 139-148
54. Soliveri P et al. (2003) A case of dementia parkinsonism resembling progressive supranuclear palsy due to mutation in the tau protein gene. Arch Neurol 60: 1454-1456
55. Tsuboi Y et al. (2005) Increased tau burden in the cortices of progressive supranuclear palsy presenting with corticobasal syndrome. Mov Disord 20: 982-988
56. Kertesz A et al. (2005) The evolution and pathology of frontotemporal dementia. Brain 128: 1996-2005
57. Hodges JR et al. (2004) Clinicopathological correlates in frontotemporal dementia. Ann Neurol 56: 399-406
58. Neary D (1997) Frontotemporal degeneration, Pick disease, and corticobasal degeneration. One entity or 3? 3. Arch Neurol 54: 1425-1427
59. Boeve BF et al. (2003) Corticobasal degeneration and its relationship to progressive supranuclear palsy and frontotemporal dementia. Ann Neurol 54 (Suppl 5): S15-S19
60. Noble W et al. (2005) Inhibition of glycogen synthase kinase-3 by lithium correlates with reduced tauopathy and degeneration in vivo. Proc Natl Acad Sci USA 102: 6990-6995